Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Pigmented hamartoma of the eyelid with apocrine, follicular and sebaceous differentiation
Journal of Cutaneous Pathology, 10/29/07
Proia, A.D., et al. - Conclusions: This case is unique because of its location and prominent melanin pigmentation. Lack of tyrosinase activity in the tumor cells and the periodic acid-Schiff (PAS) positivity of the pigment indicating its similarity to neuromelanin raise the possibility that the melanin in the hamartoma is a non-enzymatically derived oxidation product of a substance intrinsic to the tumor cells
Related Articles
Respiratory Epithelial Adenomatoid Hamartoma of the Bilateral Olfactory Recesses
American Journal of Neuroradiology, 12/08/09
Relevance Score: 83%%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/19/09
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Human Pathology, 12/19/09
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center
Leukemia and Lymphoma, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


